Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 77 to 126 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
77\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.692\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.668\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.2567\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
254.693\vspace{3pt}}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
79\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&&&\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
80\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.691\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1.25669\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
81\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CACNG5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.614\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.646\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25645\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNB5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.636\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
335.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.25304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
83\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{21}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
88.2482\vspace{3pt}}}&\multirow{21}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
110.265\vspace{3pt}}}&\multirow{21}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24949\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
84\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEE2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
85\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
86\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
87\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
88\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
89\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
90\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
91\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
92\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
93\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEB6B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
94\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
95\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
96\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
97\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
98\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEA10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGEB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAGED2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRO\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMER2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 2; homer homolog 3 (drosophila). [source:refseq;acc:nm\_004839]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.016\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.716\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
333.165\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COQ7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquinone biosynthesis protein coq7 homolog (coenzyme q biosynthesis protein 7 homolog) (timing protein clk-1 homolog). [source:swissprot;acc:q99807]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.329\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24913\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMER1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24907\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HOMER3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 3. [source:refseq;acc:nm\_004838]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.296\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.995\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24902\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.933\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
333.281\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24856\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DTX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
333.144\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.393\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2459\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DTX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
332.925\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.274\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24563\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-lak cell-originated protein kinase; spermatogenesis-related protein kinase; pdz-binding kinase; pbk; mapkk-like protein kinase; serine/threonine protein kinase. [source:refseq;acc:nm\_018492]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
332.874\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.246\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.24557\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KHDRBS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KHDRBS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KHDRBS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
268.565\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
334.483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24545\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEURL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
332.326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266.948\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24491\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFA12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
284.753\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.934\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24382\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
318.982\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
259.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23157\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21699\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cystathionine gamma-lyase (ec 4.4.1.1) (gamma-cystathionase). [source:swissprot;acc:p32929]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.655\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 3 isoform 1; sha1-related potassium channel kv4.3; voltage-gated k+ channel; potassium ionic channel kv4.3; voltage-gated potassium channel kv4.3. [source:refseq;acc:nm\_004980]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.248\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21688\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 1; shal-type potassium channel; voltage-gated potassium channel kv4.1. [source:refseq;acc:nm\_004979]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.601\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21681\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMG20B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.595\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21519\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMG20A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.588\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.778\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21429\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAMBPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
114\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21277\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/